0001127602-23-015117.txt : 20230510 0001127602-23-015117.hdr.sgml : 20230510 20230510163410 ACCESSION NUMBER: 0001127602-23-015117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230509 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wysenski Nancy CENTRAL INDEX KEY: 0001294596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 23907094 MAIL ADDRESS: STREET 1: 2200 SUNBURST STREET CITY: CHATSWORTH STATE: CA ZIP: 90401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-05-09 0001520262 Alkermes plc. ALKS 0001294596 Wysenski Nancy CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland 1 1 Ordinary Shares 2023-05-09 4 M 0 35000 31.13 A 50829 D Ordinary Shares 2023-05-09 4 M 0 6250 31.13 A 57079 D Ordinary Shares 2023-05-09 4 S 0 41250 31.2433 D 15829 D Ordinary Shares 11242 I The Nancy J. Wysenski Revocable Trust Non Qualified Stock Option (Right to Buy) 31.13 2023-05-09 4 M 0 35000 0 D 2023-05-15 Ordinary Shares 35000 0 D Non Qualified Stock Option (Right to Buy) 31.13 2023-05-09 4 M 0 6250 0 D 2023-05-15 Ordinary Shares 6250 0 D This exercise and sale of options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2023. These options were scheduled to expire on May 15, 2023. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.23 to $31.33. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. The reporting person is a trustee and a beneficiary of The Nancy J. Wysenski Revocable Trust, established on September 23, 2014 ("The Nancy J. Wysenski Revocable Trust"). These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for Nancy J. Wysenski 2023-05-10